^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Onco-ID Breast test

    Company:
    Syantra
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    It is a precision medicine blood-based screening tool that measures a panel of 12 gene expression biomarkers from whole blood using multiplexed quantitative PCR. Unlike traditional liquid biopsies that look for circulating tumor DNA, Onco-ID detects shifts in the body's immune system gene expression patterns indicative of breast cancer
    Cancer:
    Breast Cancer
    Method:
    Next-Generation Sequencing
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    01/01/26
    BC
    BCAR4
    FDA (PMA)
    Confirmatory trial(s)
    1000-000002-23
    |
    11TH Milan Breast Cancer Conference